New CT technology allows for a comprehensive, simultaneous evaluation of lung structure and function, something not possible with standard CT, according to a study published in Radiology, a journal of the Radiological Society ...
Jul 13, 2023
0
4
Pulmonary hypertension may be postcapillary—a result of an increase in pulmonary venous pressure in left-sided heart diseases—or pre-capillary, caused by pulmonary vascular remodeling or lung diseases, leading to increased ...
Jun 2, 2023
0
2
Chronic respiratory diseases (CRDs) were the third leading cause of death globally, accounting for 4.0 million deaths in 2019, according to a study published online April 25 in eClinicalMedicine.
May 18, 2023
0
25
Pulmonary hypertension, or high blood pressure in the lungs, is a common complication of interstitial lung disease, an array of conditions that cause scarring of the lungs. Without treatment, it can be life-threatening. But ...
Apr 5, 2023
0
2
Compared with capecitabine-based regimens, trastuzumab deruxtecan (T-DXd) led to higher response rates and longer survival in the third-line setting for patients with HER2-positive metastatic breast cancer previously treated ...
Dec 7, 2022
0
4
In a new study published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine, researchers sought to determine the percentage of COVID-19 patients discharged from the hospital ...
Dec 2, 2022
0
31
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, described a first-of-its-kind validated tool to screen for systemic sclerosis-associated interstitial lung disease.
Nov 8, 2022
0
4
You may be surprised to learn that the medication sildenafil—better known by its brand name Viagra—has other medical purposes aside from treating male erectile dysfunction. It can also be used to treat lung diseases that ...
Sep 29, 2022
0
9
For the first time, researchers have shown that a class of anti-fibrotic drugs slows the progression of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA). Research conducted in part at National Jewish ...
Sep 22, 2022
0
21
A recent study in the Journal of Investigative Dermatology describes the success of using lenabasum, a cannabinoid receptor type 2 (CB2) agonist that triggers the resolution of inflammation, to treat amyopathic dermatomyositis. ...
Sep 21, 2022
0
2
